中(zhong)(zhong)(zhong)证网讯(记者 傅苏颖)6月28日,由国(guo)药集(ji)团中(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)药控股有(you)(you)限公司主办、中(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)药有(you)(you)限公司承办,中(zhong)(zhong)(zhong)国(guo)中(zhong)(zhong)(zhong)医科(ke)学院中(zhong)(zhong)(zhong)药研(yan)究所、中(zhong)(zhong)(zhong)国(guo)电子(zi)技术(shu)标准化研(yan)究院提供技术(shu)支(zhi)持的“2022年产(chan)业技术(shu)基础公共(gong)服(fu)务平台项(xiang)目(mu)——中(zhong)(zhong)(zhong)药全产(chan)业链质量技术(shu)服(fu)务平台”建设项(xiang)目(mu)推进会召开。
工(gong)业和信息(xi)化(hua)部消(xiao)费品工(gong)业司(si)司(si)长何亚琼(qiong)在会(hui)上表示(shi),要充分认识(shi)加强中(zhong)(zhong)(zhong)药(yao)(yao)质(zhi)(zhi)量(liang)公(gong)共服务(wu)能(neng)力(li)建设的(de)(de)重要意义,推动解决制约中(zhong)(zhong)(zhong)药(yao)(yao)行业发(fa)展的(de)(de)突(tu)出问题,促进产(chan)业健康(kang)发(fa)展;发(fa)挥企业自身(shen)优势,引入互联网(wang)、大数据(ju)领域资源,服务(wu)行业、赋能(neng)行业,切实(shi)提(ti)升中(zhong)(zhong)(zhong)药(yao)(yao)全产(chan)业链质(zhi)(zhi)量(liang)技术公(gong)共服务(wu)水平,确(que)保“公(gong)共”属性;通过项目平台的(de)(de)搭建,提(ti)高中(zhong)(zhong)(zhong)药(yao)(yao)全产(chan)业链的(de)(de)质(zhi)(zhi)控水平,切实(shi)提(ti)升中(zhong)(zhong)(zhong)药(yao)(yao)产(chan)品质(zhi)(zhi)量(liang),全力(li)保障人民群(qun)众健康(kang)需求。
据(ju)悉,“中(zhong)(zhong)(zhong)药(yao)(yao)全(quan)(quan)产(chan)(chan)业链(lian)质量(liang)技术服(fu)(fu)务(wu)(wu)平(ping)台”建设项目由“中(zhong)(zhong)(zhong)药(yao)(yao)全(quan)(quan)产(chan)(chan)业链(lian)质量(liang)可追(zhui)溯数(shu)(shu)据(ju)平(ping)台”“中(zhong)(zhong)(zhong)药(yao)(yao)全(quan)(quan)过程质量(liang)控(kong)制检(jian)验(yan)检(jian)测(ce)平(ping)台”“中(zhong)(zhong)(zhong)药(yao)(yao)创(chuang)新成(cheng)(cheng)(cheng)果产(chan)(chan)业化公共服(fu)(fu)务(wu)(wu)平(ping)台”三部分构成(cheng)(cheng)(cheng),共建三位一(yi)体的数(shu)(shu)字(zi)(zi)化中(zhong)(zhong)(zhong)药(yao)(yao)全(quan)(quan)产(chan)(chan)业链(lian)数(shu)(shu)据(ju)信息系统(tong)。项目建成(cheng)(cheng)(cheng)后(hou)将为行业提供中(zhong)(zhong)(zhong)药(yao)(yao)产(chan)(chan)业管(guan)理(li)(li)、中(zhong)(zhong)(zhong)药(yao)(yao)新药(yao)(yao)开发、检(jian)验(yan)检(jian)测(ce)服(fu)(fu)务(wu)(wu)、快速(su)检(jian)测(ce)服(fu)(fu)务(wu)(wu)、中(zhong)(zhong)(zhong)药(yao)(yao)大品种二次开发、追(zhui)溯数(shu)(shu)字(zi)(zi)化服(fu)(fu)务(wu)(wu)、药(yao)(yao)理(li)(li)药(yao)(yao)效和(he)安全(quan)(quan)性评价、质量(liang)管(guan)理(li)(li)体系建设服(fu)(fu)务(wu)(wu)、知识(shi)服(fu)(fu)务(wu)(wu)、成(cheng)(cheng)(cheng)果转化服(fu)(fu)务(wu)(wu)、中(zhong)(zhong)(zhong)药(yao)(yao)产(chan)(chan)品或企业评价等(deng)服(fu)(fu)务(wu)(wu)。
中(zhong)国科学院院士、中(zhong)国中(zhong)医科学院首席(xi)研究(jiu)员仝小林表示,“中(zhong)药全产(chan)业链(lian)质量技术服务平台(tai)”建设项目(mu)系统整合中(zhong)药全产(chan)业链(lian)产(chan)品开发(fa)、检(jian)(jian)验(yan)检(jian)(jian)测、质量控制和质量追溯(su)等(deng)实体及数(shu)字资源,促(cu)进中(zhong)药创(chuang)新链(lian)与(yu)产(chan)业链(lian)的深度融合、激发(fa)中(zhong)药企业创(chuang)新活力(li),助力(li)中(zhong)药产(chan)业高质量发(fa)展。
中国医(yi)药(yao)(yao)集团(tuan)(tuan)有限公司(si)副总(zong)经理董增贺(he)表(biao)示,中国中药(yao)(yao)控(kong)股作为国药(yao)(yao)集团(tuan)(tuan)实现“四(si)梁八柱、百强(qiang)万亿”总(zong)体(ti)战略规(gui)划(hua)目(mu)标的重要组成部(bu)分,要以本项目(mu)实施为契机(ji),组建协(xie)(xie)同(tong)产(chan)业链网(wang)络,强(qiang)化内外战略联盟,建设数(shu)字化产(chan)学研融合服务(wu)平台(tai)和协(xie)(xie)同(tong)创(chuang)新网(wang)络,着力构筑“立体(ti)式”中药(yao)(yao)产(chan)业科(ke)技创(chuang)新和质量服务(wu)格局,整体(ti)联动(dong)推(tui)动(dong)全国中药(yao)(yao)产(chan)业体(ti)系高质量发展。
作(zuo)为国(guo)药集团现(xian)代中(zhong)药板块的(de)核心(xin)平台(tai),中(zhong)国(guo)中(zhong)药控(kong)股有限公司董事长陈(chen)映龙表示(shi),中(zhong)国(guo)中(zhong)药控(kong)股的(de)发展(zhan)战略与(yu)项目目标深度契合(he),中(zhong)国(guo)中(zhong)药控(kong)股将(jiang)带动联(lian)合(he)体成员单(dan)位,不断推进(jin)中(zhong)医药产业数字(zi)化与(yu)产业升级。
中(zhong)证(zheng)网讯(记者 傅苏颖)6月28日,由国药集(ji)团中(zhong)国中(zhong)药控股(gu)有(you)限公司主办、中(zhong)国中(zhong)药有(you)限公司承(cheng)办,中(zhong)国中(zhong)医科(ke)学院中(zhong)药研究所(suo)、中(zhong)国电子技(ji)(ji)术(shu)标准化研究院提供技(ji)(ji)术(shu)支持的“2022年产业技(ji)(ji)术(shu)基础公共服(fu)务平台项目——中(zhong)药全产业链(lian)质(zhi)量技(ji)(ji)术(shu)服(fu)务平台”建(jian)设(she)项目推(tui)进会召开。
工(gong)业(ye)(ye)和信息化部(bu)消(xiao)费品工(gong)业(ye)(ye)司司长何亚琼在(zai)会(hui)上表示,要充分认识(shi)加强中(zhong)(zhong)药质(zhi)(zhi)量公共服务能力建设的(de)重要意义(yi),推动解决制约中(zhong)(zhong)药行(xing)业(ye)(ye)发(fa)展的(de)突(tu)出问题(ti),促进产(chan)(chan)业(ye)(ye)健(jian)康发(fa)展;发(fa)挥企业(ye)(ye)自身优势,引入互联网、大数据领域(yu)资(zi)源,服务行(xing)业(ye)(ye)、赋能行(xing)业(ye)(ye),切实提(ti)(ti)升中(zhong)(zhong)药全产(chan)(chan)业(ye)(ye)链质(zhi)(zhi)量技术(shu)公共服务水(shui)平(ping),确(que)保(bao)“公共”属性;通(tong)过项目平(ping)台的(de)搭建,提(ti)(ti)高中(zhong)(zhong)药全产(chan)(chan)业(ye)(ye)链的(de)质(zhi)(zhi)控水(shui)平(ping),切实提(ti)(ti)升中(zhong)(zhong)药产(chan)(chan)品质(zhi)(zhi)量,全力保(bao)障人(ren)民群(qun)众健(jian)康需求。
据(ju)悉,“中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)全(quan)(quan)(quan)产业(ye)(ye)链(lian)质(zhi)量(liang)(liang)技术服(fu)务(wu)平台”建设项(xiang)(xiang)目由“中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)全(quan)(quan)(quan)产业(ye)(ye)链(lian)质(zhi)量(liang)(liang)可追(zhui)溯(su)数据(ju)平台”“中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)全(quan)(quan)(quan)过程(cheng)质(zhi)量(liang)(liang)控制(zhi)检验检测平台”“中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)创新(xin)(xin)成(cheng)果产业(ye)(ye)化公共(gong)服(fu)务(wu)平台”三(san)部分构(gou)成(cheng),共(gong)建三(san)位一体的数字化中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)全(quan)(quan)(quan)产业(ye)(ye)链(lian)数据(ju)信息系统。项(xiang)(xiang)目建成(cheng)后将(jiang)为行业(ye)(ye)提供中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)产业(ye)(ye)管(guan)理、中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)新(xin)(xin)药(yao)(yao)(yao)(yao)(yao)开发(fa)、检验检测服(fu)务(wu)、快速检测服(fu)务(wu)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)大品种二(er)次开发(fa)、追(zhui)溯(su)数字化服(fu)务(wu)、药(yao)(yao)(yao)(yao)(yao)理药(yao)(yao)(yao)(yao)(yao)效和安全(quan)(quan)(quan)性评(ping)价(jia)、质(zhi)量(liang)(liang)管(guan)理体系建设服(fu)务(wu)、知(zhi)识服(fu)务(wu)、成(cheng)果转化服(fu)务(wu)、中(zhong)(zhong)药(yao)(yao)(yao)(yao)(yao)产品或企(qi)业(ye)(ye)评(ping)价(jia)等服(fu)务(wu)。
中(zhong)(zhong)国(guo)科(ke)学院(yuan)院(yuan)士、中(zhong)(zhong)国(guo)中(zhong)(zhong)医(yi)科(ke)学院(yuan)首席研究员仝(tong)小林表示,“中(zhong)(zhong)药(yao)全产业链(lian)质(zhi)量(liang)技术(shu)服务平台”建设项目(mu)系统整合(he)中(zhong)(zhong)药(yao)全产业链(lian)产品开发、检验检测、质(zhi)量(liang)控制和质(zhi)量(liang)追溯等(deng)实体及数字资源(yuan),促(cu)进中(zhong)(zhong)药(yao)创(chuang)新(xin)链(lian)与产业链(lian)的(de)深度(du)融合(he)、激发中(zhong)(zhong)药(yao)企(qi)业创(chuang)新(xin)活力(li),助力(li)中(zhong)(zhong)药(yao)产业高(gao)质(zhi)量(liang)发展。
中(zhong)国(guo)(guo)医(yi)药集团(tuan)有限(xian)公司副总经理董增贺表示,中(zhong)国(guo)(guo)中(zhong)药控股作为(wei)国(guo)(guo)药集团(tuan)实现“四梁八柱、百(bai)强万(wan)亿(yi)”总体战(zhan)略(lve)规划目(mu)标的重要(yao)组(zu)成部分,要(yao)以本项目(mu)实施(shi)为(wei)契机(ji),组(zu)建协同产(chan)业(ye)链网络,强化(hua)内外战(zhan)略(lve)联盟,建设数字(zi)化(hua)产(chan)学研融合服务平台和协同创新(xin)网络,着力构筑“立(li)体式”中(zhong)药产(chan)业(ye)科(ke)技(ji)创新(xin)和质量服务格局,整(zheng)体联动(dong)推动(dong)全国(guo)(guo)中(zhong)药产(chan)业(ye)体系高(gao)质量发展。
作为国药(yao)集团现代中(zhong)(zhong)(zhong)药(yao)板块的(de)核心(xin)平台,中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)控股有限公司董事(shi)长陈映龙表(biao)示(shi),中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)控股的(de)发展(zhan)战略与项目(mu)目(mu)标深度(du)契合(he),中(zhong)(zhong)(zhong)国中(zhong)(zhong)(zhong)药(yao)控股将带动(dong)联合(he)体成(cheng)员单位,不断推进中(zhong)(zhong)(zhong)医药(yao)产业数(shu)字(zi)化与产业升级。